Phase II trial of epidermal growth factor ointment for patients with Erlotinib-related skin effects 2017-08-25 cgbio 조회수Views : 637 다음글Prospective randomized comparison of scar appearances between cograft of acellular dermal matrix with autologous split-thickness skin and autologous split-thickness skin graft alone for full-thickness skin defects of the extremities 이전글Evaluation of an antimicrobial silver foam dressing
